|Articles|May 17, 2004
Hospitals start pilot testing RFID to curb drug diversion
M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Shifting from Reactive to Proactive Diabetes Counselors
2
Naloxone Sales Highlight Limited OTC Use, Access Challenges
3
Is it Safe for Birth Control Users to Go Years Without a Period?
4
MDPNP Implementation Will Be Complex Despite Systems Properly in Place | NCPA 2025
5
















































































































































